BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38044714)

  • 1. CAMTA1-related disorder: Phenotypic and molecular characterization of 26 new individuals and literature review.
    Al-Kateb H; Au PYB; Berland S; Cogne B; Demurger F; Fluss J; Isidor B; Frank LM; Varvagiannis K; Koolen DA; McDonald M; Montgomery S; Moortgat S; Deprez M; Karadurmus D; Paulsen J; Reis A; Rieger M; Vasileiou G; Willing M; Shinawi M
    Clin Genet; 2024 Mar; 105(3):294-301. PubMed ID: 38044714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes.
    Shinawi M; Coorg R; Shimony JS; Grange DK; Al-Kateb H
    Clin Genet; 2015 May; 87(5):478-82. PubMed ID: 24738973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the molecular spectrum and the neurological phenotype related to CAMTA1 variants.
    Jacobs EZ; Brown K; Byler MC; D'haenens E; Dheedene A; Henderson LB; Humberson JB; van Jaarsveld RH; Kanani F; Lebel RR; Millan F; Oegema R; Oostra A; Parker MJ; Rhodes L; Saenz M; Seaver LH; Si Y; Vanlander A; Vergult S; Callewaert B
    Clin Genet; 2021 Feb; 99(2):259-268. PubMed ID: 33131045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.
    Dzinovic I; Serranová T; Prouteau C; Colin E; Ziegler A; Winkelmann J; Jech R; Zech M
    Neurogenetics; 2021 May; 22(2):137-141. PubMed ID: 33677721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo variants in CAMTA1 cause a syndrome variably associated with spasticity, ataxia, and intellectual disability.
    Wijnen IGM; Veenstra-Knol HE; Vansenne F; Gerkes EH; de Koning T; Vos YJ; Tijssen MAJ; Sival D; Darin N; Vanhoutte EK; Oosterloo M; Pennings M; van de Warrenburg BP; Kamsteeg EJ
    Eur J Hum Genet; 2020 Jun; 28(6):763-769. PubMed ID: 32157189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological and neuroimaging phenotype induced by a CAMTA1 mutation.
    Magnin E; Blagosklonov O; Sylvestre G; Minot D; Thevenon J; Faivre L; Boulahdour H; Thauvin-Robinet C; Rumbach L
    Brain Dev; 2014 Sep; 36(8):711-5. PubMed ID: 24145135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intragenic CAMTA1 rearrangements cause non-progressive congenital ataxia with or without intellectual disability.
    Thevenon J; Lopez E; Keren B; Heron D; Mignot C; Altuzarra C; Béri-Dexheimer M; Bonnet C; Magnin E; Burglen L; Minot D; Vigneron J; Morle S; Anheim M; Charles P; Brice A; Gallagher L; Amiel J; Haffen E; Mach C; Depienne C; Doummar D; Bonnet M; Duplomb L; Carmignac V; Callier P; Marle N; Mosca-Boidron AL; Roze V; Aral B; Razavi F; Jonveaux P; Faivre L; Thauvin-Robinet C
    J Med Genet; 2012 Jun; 49(6):400-8. PubMed ID: 22693284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance.
    Huentelman MJ; Papassotiropoulos A; Craig DW; Hoerndli FJ; Pearson JV; Huynh KD; Corneveaux J; Hänggi J; Mondadori CR; Buchmann A; Reiman EM; Henke K; de Quervain DJ; Stephan DA
    Hum Mol Genet; 2007 Jun; 16(12):1469-77. PubMed ID: 17470457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic expansion of Bosch-Boonstra-Schaaf optic atrophy syndrome and further evidence for genotype-phenotype correlations.
    Rech ME; McCarthy JM; Chen CA; Edmond JC; Shah VS; Bosch DGM; Berry GT; Williams L; Madan-Khetarpal S; Niyazov D; Shaw-Smith C; Kovar EM; Lupo PJ; Schaaf CP
    Am J Med Genet A; 2020 Jun; 182(6):1426-1437. PubMed ID: 32275123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotypic spectrum and genotype-phenotype correlations in 106 patients with variants in major autism gene CHD8.
    Dingemans AJM; Truijen KMG; van de Ven S; Bernier R; Bongers EMHF; Bouman A; de Graaff-Herder L; Eichler EE; Gerkes EH; De Geus CM; van Hagen JM; Jansen PR; Kerkhof J; Kievit AJA; Kleefstra T; Maas SM; de Man SA; McConkey H; Patterson WG; Dobson AT; Prijoles EJ; Sadikovic B; Relator R; Stevenson RE; Stumpel CTRM; Heijligers M; Stuurman KE; Löhner K; Zeidler S; Lee JA; Lindy A; Zou F; Tedder ML; Vissers LELM; de Vries BBA
    Transl Psychiatry; 2022 Oct; 12(1):421. PubMed ID: 36182950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Calmodulin Binding Transcription Activator 1 (CAMTA1) gene and its putative genetic partners in the human nervous system.
    Alves G; Ornellas MH; Liehr T
    Psychogeriatrics; 2022 Nov; 22(6):869-878. PubMed ID: 35949142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calmodulin-binding transcription activator CAMTA1 is required for long-term memory formation in mice.
    Bas-Orth C; Tan YW; Oliveira AM; Bengtson CP; Bading H
    Learn Mem; 2016 Jun; 23(6):313-21. PubMed ID: 27194798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle-dependent transcriptional regulation of calmodulin-binding transcription activator 1 in neuroblastoma cells.
    Nakatani K; Nishioka J; Itakura T; Nakanishi Y; Horinouchi J; Abe Y; Wada H; Nobori T
    Int J Oncol; 2004 Jun; 24(6):1407-12. PubMed ID: 15138581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder.
    Kumble S; Levy AM; Punetha J; Gao H; Ah Mew N; Anyane-Yeboa K; Benke PJ; Berger SM; Bjerglund L; Campos-Xavier B; Ciliberto M; Cohen JS; Comi AM; Curry C; Damaj L; Denommé-Pichon AS; Emrick L; Faivre L; Fasano MB; Fiévet A; Finkel RS; García-Miñaúr S; Gerard A; Gomez-Puertas P; Guillen Sacoto MJ; Hoffman TL; Howard L; Iglesias AD; Izumi K; Larson A; Leiber A; Lozano R; Marcos-Alcalde I; Mintz CS; Mullegama SV; Møller RS; Odent S; Oppermann H; Ostergaard E; Pacio-Míguez M; Palomares-Bralo M; Parikh S; Paulson AM; Platzer K; Posey JE; Potocki L; Revah-Politi A; Rio M; Ritter AL; Robinson S; Rosenfeld JA; Santos-Simarro F; Sousa SB; ; Wéber M; Xie Y; Chung WK; Brown NJ; Tümer Z
    Hum Mutat; 2022 Feb; 43(2):266-282. PubMed ID: 34859529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo CLTC variants are associated with a variable phenotype from mild to severe intellectual disability, microcephaly, hypoplasia of the corpus callosum, and epilepsy.
    Nabais Sá MJ; Venselaar H; Wiel L; Trimouille A; Lasseaux E; Naudion S; Lacombe D; Piton A; Vincent-Delorme C; Zweier C; Reis A; Trollmann R; Ruiz A; Gabau E; Vetro A; Guerrini R; Bakhtiari S; Kruer MC; Amor DJ; Cooper MS; Bijlsma EK; Barakat TS; van Dooren MF; van Slegtenhorst M; Pfundt R; Gilissen C; Willemsen MA; de Vries BBA; de Brouwer APM; Koolen DA
    Genet Med; 2020 Apr; 22(4):797-802. PubMed ID: 31776469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAMTA 1 regulates drought responses in Arabidopsis thaliana.
    Pandey N; Ranjan A; Pant P; Tripathi RK; Ateek F; Pandey HP; Patre UV; Sawant SV
    BMC Genomics; 2013 Apr; 14():216. PubMed ID: 23547968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo nonsense and frameshift variants of TCF20 in individuals with intellectual disability and postnatal overgrowth.
    Schäfgen J; Cremer K; Becker J; Wieland T; Zink AM; Kim S; Windheuser IC; Kreiß M; Aretz S; Strom TM; Wieczorek D; Engels H
    Eur J Hum Genet; 2016 Dec; 24(12):1739-1745. PubMed ID: 27436265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental and other phenotypes recurrently associated with heterozygous BAZ2B loss-of-function variants.
    Sewani S; Azamian MS; Mendelsohn BA; Mau-Them FT; Réda M; Nambot S; Isidor B; van der Smagt JJ; Shen JJ; Shillington A; White L; Elloumi HZ; Baker PR; Svihovec S; Brown K; Koopman-Keemink Y; Hoffer MJV; Lakeman IMM; Brischoux-Boucher E; Kinali M; Zhao X; Lalani SR; Scott DA
    Am J Med Genet A; 2024 Mar; 194(3):e63445. PubMed ID: 37872713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrator of Stress Responses Calmodulin Binding Transcription Activator 1 (Camta1) Regulates miR-212/miR-132 Expression and Insulin Secretion.
    Mollet IG; Malm HA; Wendt A; Orho-Melander M; Eliasson L
    J Biol Chem; 2016 Aug; 291(35):18440-52. PubMed ID: 27402838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.